Laser Biotech International

Laser Biotech International manufactures Lumix superpulsed biostimulative laser systems for clinical applications in pain relief, tissue repair, and accelerated healing. Founded by Dr. Nelson Marquina, an engineer, physician, and international laser expert, the company introduced superpulsed laser therapy to the US market and earned FDA 510(k) clearance in 2004. The Lumix product line features Class 3b and Class 4 FDA-cleared configurations combining superpulsed and continuous-wave wavelengths (2–5 wavelengths depending on model) to deliver superior tissue penetration, photon density, and therapeutic outcomes. Systems are designed for sports medicine, chiropractic, dentistry, physiotherapy, and rehabilitation centers. Lumix lasers reduce inflammation, promote cellular regeneration, stimulate collagen production, and provide drug-free pain relief without opioid addiction risk. Key clinical benefits include deep tissue penetration reaching joints, muscles, and organs; faster recovery times; minimal thermal buildup; and intuitive touchscreen controls with built-in treatment protocols. The company emphasizes peer-reviewed research backing, decades of clinical validation, and direct technical support grounded in Dr. Marquina's background in bioelectromagnetics, human physiology, and clinical practice. Product models include Lumix-45W, Lumix CPS, and Lumix Q. Target markets span both clinical and rehabilitation settings seeking non-invasive, effective pain management and tissue healing solutions.